Evidence map›Paper›PMID 35890644›Full record

ArticlePolymers2022

5-Fluorouracil and Curcumin Combination Coated with Pectin and Its Strategy towards Titanium Dioxide, Dimethylhydrazine Colorectal Cancer Model with the Evaluation of the Blood Parameters.

Chenmala Karthika, Md Habibur Rahman, Raman Sureshkumar, Rokeya Akter, Azmat Ali Khan, Amer M Alanazi, Abul Kalam Azad, Paritosh Barai, Hasi Rani Barai

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Chenmala KarthikaDepartment of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty 643001, India.ORCID 0000-0001-7874-6521
Md Habibur RahmanDepartment of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Korea.ORCID 0000-0001-6099-5693
Raman SureshkumarDepartment of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty 643001, India.
Rokeya AkterDepartment of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Korea.
Azmat Ali KhanPharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Amer M AlanaziPharmaceutical Biotechnology Laboratory, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Abul Kalam AzadFaculty of Pharmacy, MAHSA, Bandar Saujana Putra, Jenjarom 42610, Selangor, Malaysia.ORCID 0000-0003-4874-1169
Paritosh BaraiDepartment of Biochemistry and Molecular Biology, Primeasia University, Dhaka 1213, Bangladesh.
Hasi Rani BaraiSchool of Mechanical and IT Engineering, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0001-5915-8425
JSS Academy of Higher Education and Research · INKing Saud University · SAYonsei University · KRMahsa University · MYPrimeasia University · BDYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is considered the third most common cancer and the second leading cause of death globally. It has been proven that titanium dioxide nanoparticles produce oxidative stress and can lead to chronic inflammation, which could turn into diseases like cancer, cardiovascular disorders, diabetes, and so on. To evaluate the effect of 5-fluorouracil (5-FU) curcumin (CUR) conjugate coated with pectin on colorectal cancer induced by titanium dioxide nanoparticles (TiO

Indexed as

5-fluorouracilcolorectal cancercurcumindimethylhydrazinepectintitanium dioxide nanoparticles

Identifiers

PMID35890644
PMCPMC9316185
OpenAlexW4285594577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.